Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556579 · ClinicalTrials.gov registry record · NA
The Effects of Contact Lenses With Experimental Dye on Visual Function
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT03556579 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 62 participants.
The verdict
NCT03556579, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This is a single-site, two-visit, contralateral, non-dispensing, randomized, controlled and subject-masked study to measure potential benefits of the new UV blocker.
Interventions
- DEVICE senofilcon A
- DEVICE senofilcon A with new UV blocker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2018-05-15 |
| Est. Completion | 2018-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03556579
The ClinicalTrials.gov registry entry for NCT03556579 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.
NCT03556579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03556579 about?
NCT03556579 is a clinical study titled "The Effects of Contact Lenses With Experimental Dye on Visual Function". This is a single-site, two-visit, contralateral, non-dispensing, randomized, controlled and subject-masked study to measure potential benefits of the new UV blocker.
What is the current status of trial NCT03556579?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2018-05-15. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT03556579?
The interventions under investigation include: senofilcon A (DEVICE), senofilcon A with new UV blocker (DEVICE).
Who is sponsoring clinical trial NCT03556579?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.